NIH launches addiction study.
In response to the growing problem of prescription drug abuse, officials at the National Institutes of Health are launching the Prescription Opioid Addiction Treatment Study (POATS), a multisite study to be conducted under the direction of the National Institute on Drug Abuse. The researchers will examine the effectiveness of buprenorphine/naloxone (Suboxone) combined with either intensive or brief drug-counseling approaches. Investigators are planning to enroll about 648 participants at 11 sites. "Opioid analgesics were designed to help people in pain and we want to be sure that those who require them for legitimate reasons can continue to effectively manage their pain," Dr. Nora D. Volkow, director of NIDA, said in a statement. "However, we must also recognize the risk of addiction to pain medications and develop treatments for those who become addicted to them. This trial is an important first step in reaching that goal."
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||POLICY & PRACTICE; National Institutes of Health|
|Author:||Schneider, Mary Ellen|
|Publication:||Clinical Psychiatry News|
|Article Type:||Brief article|
|Date:||Apr 1, 2007|
|Previous Article:||Mental health court cut costs.|
|Next Article:||FDA to study ads' risk data.|